RxDoctor Payments Data

Spencer Ochner

Physician Assistant · Glen Rock, NJNPI 1386371599

Payments from drug & device makers

$3,301in general payments, 2019–2025

Across 185 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$501
  • Amgen$493
  • Novo Nordisk$418
  • Exact Sciences$317
  • AstraZeneca$292
  • Lilly USA, LLC$284
  • plus $997 from 18 others

What the payments were for

  • Food & beverage$3,301100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,301 in reported general payments places this provider in the 90th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide101$117,996
JardianceEmpagliflozin62$67,133
FarxigaDapagliflozin Propanediol42$62,194
JanuviaSitagliptin Phosphate39$60,993
MounjaroTirzepatide42$53,349
LinzessLinaclotide62$48,076
VascepaIcosapent Ethyl27$21,359
JanumetSitagliptin Phos/Metformin Hcl19$18,168
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$17,434
TrulicityDulaglutide11$17,339
RybelsusSemaglutide11$17,271
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$12,635
XareltoRivaroxaban12$10,343
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$8,167
Omega-3 Acid Ethyl Esters55$6,175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$418$135,267112 claims
MerckJanuvia, Janumet$59$79,16158 claims
Lilly USA, LLCMounjaro, Trulicity$284$70,68853 claims
Boehringer IngelheimJardiance$17$67,13362 claims
AstraZenecaFarxiga, Symbicort$292$65,72958 claims
GSKTrelegy Ellipta, Anoro Ellipta$138$30,06843 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Glen Rock

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →